[{"Assets_0_Q3_USD":5876100.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-5968300.0,"NetIncomeLoss_1_Q3_USD":-2638500.0,"NetIncomeLoss_3_Q3_USD":-7706700.0,"StockholdersEquity_0_Q3_USD":2588600.0,"Ticker":"VTGN","CIK":"1411685","name":"VISTAGEN THERAPEUTICS, INC.","OfficialName":"VistaGen Therapeutics Inc. Common Stock","form":"10-Q","period":"20161231","fy":"2016.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309791933.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170213"}]